BrownJA, BourkeE, ErikssonLA, et al. (2016). Targeting cancer using KAT inhibitors to mimic lethal knockouts. Biochem Soc Trans, 44, 979–986.
2.
GorriniC, SquatritoM, LuiseC, et al. (2007). Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature, 448, 1063–1067.
3.
IdrissouM, BoisnierT, SanchezA, et al. (2020a). TIP60/P400/H4K12ac plays a role as a heterochromatin back-up skeleton in breast cancer. Cancer Genom Proteom, 17, 687–694.
4.
IdrissouM, LebertA, BoisnierT, et al. (2020b). Digging deeper into breast cancer epigenetics: Insights from chemical inhibition of histone acetyltransferase TIP60 in vitro. OMICS, 24, 581–591.
5.
McguireA, CaseyMC, ShalabyA, et al. (2019). Quantifying Tip60 (Kat5) stratifies breast cancer. Sci Rep, 9, 3819.
6.
RajagopalanD, Tirado-MagallanesR, BhatiaSS, et al. (2018). TIP60 represses activation of endogenous retroviral elements. Nucleic Acids Res, 46, 9456–9470.
